Form 4: Emergent BioSolutions Executive Jennifer Fox Reports Stock Transaction
SEC Form 4 Filing
Jennifer Lynne Fox, EVP, Ext Aff, GC, Corp Sec of Emergent BioSolutions Inc., reports disposition of shares to cover tax obligations.
Summary
- On June 8, 2024, Jennifer Lynne Fox, an executive at Emergent BioSolutions Inc., reported a transaction involving the company's common stock.
- A total of 2,376 shares were disposed of at a price of $6.19 per share to cover tax obligations.
- Following the transaction, Fox directly owns 171,382 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents a routine transaction to cover tax obligations, which is a normal part of executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/08/2024 | Date of stock transaction |
| 06/11/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.